Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now

INSP reported improved results driven by stronger demand and margin expansion as its Inspire V gains traction. However, reimbursement shifts and the ongoing WISeR rollout introduce near-term headwinds and uncertainty for guidance. Expect the stock to react as investors weigh durable demand and margin gains against reimbursement risk and execution on WISeR (likely stock moves in the ~1–3% range).

Analysis

INSP reported improved results driven by stronger demand and margin expansion as its Inspire V gains traction. However, reimbursement shifts and the ongoing WISeR rollout introduce near-term headwinds and uncertainty for guidance. Expect the stock to react as investors weigh durable demand and margin gains against reimbursement risk and execution on WISeR (likely stock moves in the ~1–3% range).